Sanders Morris Harris LLC Purchases New Shares in HCA Healthcare, Inc. $HCA

Sanders Morris Harris LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,781 shares of the company’s stock, valued at approximately $1,611,000.

Several other institutional investors have also recently bought and sold shares of HCA. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. Brooklyn Investment Group increased its position in shares of HCA Healthcare by 32.5% in the 1st quarter. Brooklyn Investment Group now owns 1,489 shares of the company’s stock valued at $514,000 after buying an additional 365 shares in the last quarter. Korea Investment CORP grew its stake in HCA Healthcare by 2.0% in the first quarter. Korea Investment CORP now owns 194,677 shares of the company’s stock valued at $67,271,000 after acquiring an additional 3,752 shares during the period. RWA Wealth Partners LLC raised its position in shares of HCA Healthcare by 2.0% during the first quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock worth $658,000 after purchasing an additional 37 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S increased its stake in HCA Healthcare by 21.6% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 117,677 shares of the company’s stock worth $40,663,000 after purchasing an additional 20,934 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research report on Monday, October 27th. Oppenheimer raised their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. KeyCorp raised their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. UBS Group raised their price target on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, The Goldman Sachs Group boosted their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $475.95.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $469.39 on Wednesday. The company has a fifty day moving average price of $467.09 and a two-hundred day moving average price of $415.42. The stock has a market cap of $107.11 billion, a price-to-earnings ratio of 18.14, a price-to-earnings-growth ratio of 1.41 and a beta of 1.36. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.